Domo signs strategic collaboration agreement with AWS for AI solutions
BANNOCKBURN, Ill. - Option Care Health, Inc. (NASDAQ:OPCH) announced Wednesday the appointment of Meenal Sethna as Executive Vice President and Chief Financial Officer, effective October 1, 2025. Sethna will replace Mike Shapiro, who is stepping down after 10 years with the company.
Shapiro will remain with Option Care Health as a Strategic Advisor through at least the first quarter of 2026 to ensure a smooth transition and continue supporting the company’s strategic initiatives.
Sethna joins Option Care Health with over 30 years of experience across multiple industries. She most recently served as Executive Vice President and CFO at Littelfuse, Inc. (NASDAQ:LFUS), where she oversaw finance, accounting, tax, treasury, investor relations, information technology, and supply chain operations. During her tenure at Littelfuse, the company maintained strong financial metrics, with current revenue of $2.26 billion and a market capitalization of $6.24 billion. According to InvestingPro data, Littelfuse has demonstrated solid financial management with a healthy current ratio of 4.06 and has raised its dividend for 15 consecutive years.
Prior to Littelfuse, Sethna held positions as Vice President and Corporate Controller at Illinois Tool Works and various roles at Motorola Inc. and Baxter International. She currently serves on the Board of Directors of SPX Technologies.
"She brings significant leadership and a history of thoughtful capital deployment, with a proven track record of driving sustainable growth," said John C. Rademacher, President and Chief Executive Officer of Option Care Health, in a press release statement.
Shapiro, who has been with Option Care Health since it became an independent company, will step down effective September 30, 2025. During his tenure, he helped strengthen the company’s financial position and developed its finance team.
Option Care Health describes itself as the nation’s largest independent provider of home and alternate site infusion services, with over 8,000 team members including more than 5,000 clinicians operating in all 50 states. Want deeper insights into Option Care Health’s financial health and growth potential? InvestingPro offers comprehensive analysis through its Pro Research Reports, available for over 1,400 US stocks, helping investors make informed decisions with expert analysis and actionable intelligence.
In other recent news, Littelfuse Inc. reported a robust second quarter for 2025, with earnings and revenue exceeding market expectations. The company’s earnings per share reached $2.85, surpassing the projected $2.33, while revenue amounted to $613 million, beating the anticipated $576.65 million. Oppenheimer responded to this strong performance by raising its price target for Littelfuse to $325 from $275 and maintaining an Outperform rating, citing a "broadening recovery" across multiple segments. Benchmark, on the other hand, maintained its Hold rating, noting solid performance in the Industrial and Transportation segments, despite some weakness in power semiconductors. Additionally, Littelfuse has appointed Dr. Karim Hamed as Senior Vice President and General Manager of its Semiconductor Business, bringing over 20 years of industry experience. Dr. Hamed’s previous roles include leadership positions at Analog Devices. These developments reflect Littelfuse’s continued growth and strategic leadership changes.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.